Back to UBS Group AG UBS Group AG

SXTCSXTC
2 quarters

Position history for UBS Group AGUBS Group AG's holdings in CHINA SXT PHARMACEUTICALS IN

Yes. Ubs holds 1 shares of SXTC (China SXT Pharmaceuticals in), worth $2, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Ubs has held SXTC since Q1 2026, across 2 quarterly 13F filings.

Current Value

$2

Current Shares

1

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1
0.0%
$20.0%$16,880.00
0
2026-Q1
New
1
-
$20.0%$13,440.00
17

Other major holders of SXTC: ROYAL BANK OF CANADA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used